However, protective effects of pharmacological TRPC5 inhibition have not been seen by all investigators [48], and the over-expression of either wild-type or dominant-negative TRPC5 channels in glomeruli does not appear to induce kidney disease [48], in contrast to what is seen with over-expression of TRPC6 [16,17]. Here, TRPC6 is linked to kidney disorder.